You're reading the free version. Trader adds the live tape and alerts.
Start tracking
ORKA Sale Disclosure
Klein Lawrence Otto · SEC Form 4 · Filed Oct 2, 2026
Sale
Calculated transaction value
$16.96K
Klein Lawrence Otto Chief Executive Officer
ORKA
Oruka Therapeutics
ORKA
Transaction date
Oct 1, 2026
Public filing date
Oct 2, 2026
Filing lag
Filed 1 day later
ORKA daily price context
Close on/before transaction
$83.42
Oct 1, 2026
First close after public filing
$84.38
Oct 5, 2026
30-day return after filing
+13.1%
Through Nov 2, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 200 shares @ $84.78
- SEC ownership
- Direct
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0000907654-26-000104
Filing cohort
Transactions in this filing
Showing 5 of 5
Trades
5
Issuers
1
Estimated value
$2.29M
Buys / sales
0 / 3
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Oruka Therapeutics, Inc. ORKA | Exercise | Oct 1, 2026 | $195K |
| Oruka Therapeutics, Inc. ORKA | Sale | Oct 1, 2026 | $1.35M |
| Oruka Therapeutics, Inc. ORKA | Sale | Oct 1, 2026 | $718.75K |
| Oruka Therapeutics, Inc. ORKA Current | Sale | Oct 1, 2026 | $16.96K |
| Oruka Therapeutics, Inc. ORKA | Exercise | Oct 1, 2026 | $0 |